Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 84

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

852	NVLX That loud noise you hear coming from	stocklegend	04/09/2014 12:24:00 PM
851	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/09/2014 11:09:00 AM
850	NVLX Pancreatic Cancer Cures?	stocklegend	04/09/2014 10:14:41 AM
849	NVLX news:	stocklegend	04/09/2014 8:57:39 AM
848	News looking great!	stocklegend	04/08/2014 3:51:16 PM
847	NVLX Nuvilex's proprietary Cell-in-a-Box	stocklegend	04/08/2014 3:05:29 PM
846	NVLX "Dr. Rabe is Chairman of Medical Marijuana	stocklegend	04/08/2014 2:16:27 PM
845	Dr. Rabe's presentation, "Targeted	stocklegend	04/08/2014 1:12:47 PM
844	NVLX The conference, hosted by Americans for Safe	stocklegend	04/08/2014 11:15:18 AM
843	Medical Marijuana Sciences' Dr. Mark L. Rabe	stocklegend	04/08/2014 10:06:52 AM
842	NVLX news:	stocklegend	04/08/2014 9:37:28 AM
841	NVLX Dr.Von Hoff is the one who developed	stocklegend	04/07/2014 4:08:18 PM
840	NVLX Hot News:	stocklegend	04/07/2014 2:54:04 PM
839	NVLX The Nuvilex team presents us with a new tool	stocklegend	04/07/2014 1:44:11 PM
838	NVLX That loud noise you hear coming from	stocklegend	04/07/2014 11:46:28 AM
837	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/07/2014 10:13:12 AM
836	NVLX Pancreatic Cancer Cures?	stocklegend	04/07/2014 9:20:38 AM
835	NVLX Pancreatic Cancer Cures?	stocklegend	04/04/2014 1:55:45 PM
834	NVLX Dr.Von Hoff is the one who developed	stocklegend	04/04/2014 1:06:50 PM
833	NVLX Hot News:	stocklegend	04/04/2014 11:56:20 AM
832	NVLX The Nuvilex team presents us with a new tool	stocklegend	04/04/2014 11:04:02 AM
831	NVLX That loud noise you hear coming from	stocklegend	04/04/2014 10:17:36 AM
830	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/04/2014 9:13:44 AM
829	NVLX Translational Drug Development or TD2 will	stocklegend	04/03/2014 2:04:45 PM
828	NVLX Dr. Daniel Von Hoff, the world's leading	stocklegend	04/03/2014 1:10:23 PM
827	NVLX That loud noise you hear coming from	stocklegend	04/03/2014 11:15:31 AM
826	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/03/2014 10:05:15 AM
825	NVLX Pancreatic Cancer Cures?	stocklegend	04/03/2014 9:16:18 AM
824	NVLX Dr.Von Hoff is the one who developed	stocklegend	04/02/2014 1:57:20 PM
823	NVLX Hot News:	stocklegend	04/02/2014 12:32:50 PM
822	NVLX The Nuvilex team presents us with a new tool	stocklegend	04/02/2014 11:53:13 AM
821	NVLX About Nuvilex: Nuvilex is a clinical-stage	stocklegend	04/02/2014 10:51:16 AM
820	NVLX A clinical-stage international	stocklegend	04/02/2014 10:00:40 AM
819	NVLX Pancreatic Cancer Cures?	stocklegend	04/02/2014 9:03:46 AM
818	Dr. Von Hoff is THE LEADING FIGURE in pancreatic	Tandrel	04/02/2014 9:03:17 AM
817	NVLX "We are honored that TD2 and Dr. Von Hoff	stocklegend	04/01/2014 2:25:58 PM
816	NVLX The PCRT, an affiliate of TD2, has the	stocklegend	04/01/2014 1:20:46 PM
815	NVLX Dr. Von Hoff is the one who developed	stocklegend	04/01/2014 12:14:36 PM
814	NVLX "Our Pancreatic Cancer Research Team (PCRT)	stocklegend	04/01/2014 11:29:49 AM
813	NVLX "The Nuvilex team presents us with a new	stocklegend	04/01/2014 10:15:37 AM
812	NVLX NEWS:	stocklegend	04/01/2014 9:35:17 AM
811	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	04/01/2014 9:08:03 AM
810	$NVLX With live-cell encapsulation, depending on	Tandrel	04/01/2014 8:27:23 AM
809	$NVLX ~ Here's a simple Nuvilex chart:	Tandrel	04/01/2014 8:25:12 AM
808	$NVLX's live-cell encapsulation technology is a	Tandrel	04/01/2014 8:23:22 AM
807	$NVLX Investors Confidently Back Nuvilex's	stocklegend	03/31/2014 1:57:24 PM
806	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	03/31/2014 1:47:30 PM
805	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	03/31/2014 12:48:10 PM
804	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	03/31/2014 11:07:25 AM
803	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	03/31/2014 10:21:04 AM

Newer

Older

Recent Articles

• Investors Urged to Act on Evolv Technologies Securities Violations
• Important Updates for Shareholders of Xiao-I Corporation
• Key Steps for Xerox Holdings Corp Shareholders Regarding Class Action
• PACS Group, Inc. Shareholders Face Class Action Lawsuit Risks
• Key Information for Humacyte, Inc. Investors in Class Action
• Deadline Approaches for Chipotle Lawsuit Shareholders – Act Now
• Lilium N.V. Faces Class Action Lawsuit Over Fundraising Claims
• Important Update for Hasbro, Inc. Investors on Pending Class Action
• Zoom Video's Q3 Results Show Stable Growth, But Challenges Ahead
• Inter-American Development Bank Launches $10 Million Debt Notes
• FIVE Holdings Reports Strong Q3 Growth, Revenue Soars
• Frontline Ltd Navigates Market Challenges with Resilience
• CaliberCos Faces Challenges as Stock Hits New Low of $0.45
• Antitrust Trial Against Google to Proceed Without Delays
• Bitcoin Faces Critical Support Test as Price Drops Towards $90K
• CryptoQuant CEO Shares Insights on Bitcoin's Market Shifts
• Expert Insights on Abercrombie & Fitch's Options Trends
• Analyzing Workday's Options Trading Landscape and Insights
• Understanding Blackstone's Strategic Options Trading Moves
• VinFast Achieves Impressive Q3 Sales Growth and Vehicle Delivery Success
• Shineco Inc's Stock Struggles: Analyzing Recent Developments
• Banzai International Faces Challenges as BNZI Stock Hits Low
• StealthGas Facing Challenges Yet Shows Strong Financial Potential
• Seaboard Corp Faces Challenges with Recent Stock Decline
• CBOE Holdings Achieves New Heights with $216.97 Stock Price
• Gladstone Land Achieves New Milestone with Stock Surge
• Commvault's Stock Breaks Records: A Closer Look at CVLT
• Anheuser-Busch InBev Initiates Bond Buyback Strategy in EUR/GBP
• Gladstone Commercial Reaches Milestone with 52-Week High
• Global Companies Adjust Currency Strategies Amid Trade Uncertainty
• Traditional Pay TV Faces Challenges as Streaming Dominates
• Trading Opportunities Rise as Israeli Market Volatility Peaks
• UBS Reassesses U.S. Airline Stocks with Buy Ratings
• TOYO Co. Secures Major Contract Boosting Share Prices
• Impact of Canopy USA’s Acquisition on Acreage Shareholders
• Class Action Lawsuit Deadlines Approaching for Investors
• Insights on Options Activity for Intuitive Machines Stock
• Smart Investors Maneuver in Spotify Options Market Insights
• Recent Trends in Trump Media's Options Activity
• Could Elon Musk Make a Bold Move and Buy MSNBC?
• Wolfspeed Investors Sued Amid Disappointing Financial Results
• Maxeon Solar Technologies: Strategic Shift to U.S. Market
• Legal Action Initiated Against Match Group Amid Investor Concern
• Wohl & Fruchter Investigating TKO Group Holdings Directors
• Why Exact Sciences Corp. Stock Sees Gains After CMS Decision
• Amazon Leads in Holiday Spending Amidst Retail Competition
• Automakers Face Stock Decline as Tariff Threat Looms
• American Woodmark Faces Challenges Amid Housing Market Decline
• Understanding Class Actions: Key Insights for Investors
• Insights into Dollar General's Recent Unusual Options Activity